Enzalutamide withdrawal syndrome: is there a rationale?

BJU Int. 2015 Mar;115(3):348-9. doi: 10.1111/bju.12908.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Androgen Antagonists / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Benzamides
  • Humans
  • Male
  • Nitriles
  • Phenylthiohydantoin / adverse effects
  • Phenylthiohydantoin / analogs & derivatives*
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Androgen Antagonists
  • Antineoplastic Agents
  • Benzamides
  • Nitriles
  • Phenylthiohydantoin
  • enzalutamide